These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16311896)

  • 1. Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder.
    Hofer A; Rettenbacher MA; Widschwendter CG; Kemmler G; Hummer M; Fleischhacker WW
    Eur Arch Psychiatry Clin Neurosci; 2006 Jun; 256(4):246-55. PubMed ID: 16311896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between insight and self-reported quality of life among shizophrenic patients].
    Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
    Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
    Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
    J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The subjective quality of life of patients with schizophrenia: influence of psychopathology and patients' expectations. A comparative study].
    Salomé F; Petitjean F; Germain C; Demant JC
    Encephale; 2004; 30(1):60-8. PubMed ID: 15029078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia?
    Pinna F; Sanna L; Perra V; Pisu Randaccio R; Diana E; Carpiniello B;
    Riv Psichiatr; 2014; 49(1):41-9. PubMed ID: 24572583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.
    Freudenreich O; Cather C; Evins AE; Henderson DC; Goff DC
    J Clin Psychiatry; 2004 Oct; 65(10):1372-6. PubMed ID: 15491241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia.
    Woon PS; Chia MY; Chan WY; Sim K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):463-8. PubMed ID: 20109511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates, change and 'state or trait' properties of insight in schizophrenia.
    Wiffen BD; Rabinowitz J; Lex A; David AS
    Schizophr Res; 2010 Sep; 122(1-3):94-103. PubMed ID: 20382507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facial emotion recognition and its relationship to symptomatic, subjective, and functional outcomes in outpatients with chronic schizophrenia.
    Hofer A; Benecke C; Edlinger M; Huber R; Kemmler G; Rettenbacher MA; Schleich G; Wolfgang Fleischhacker W
    Eur Psychiatry; 2009 Jan; 24(1):27-32. PubMed ID: 18774270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones.
    Iasevoli F; Giordano S; Balletta R; Latte G; Formato MV; Prinzivalli E; De Berardis D; Tomasetti C; de Bartolomeis A
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():34-48. PubMed ID: 26320028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia.
    Hofer A; Kemmler G; Eder U; Honeder M; Hummer M; Fleischhacker WW
    J Clin Psychiatry; 2002 Jan; 63(1):49-53. PubMed ID: 11838626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects.
    Hofer A; Baumgartner S; Edlinger M; Hummer M; Kemmler G; Rettenbacher MA; Schweigkofler H; Schwitzer J; Fleischhacker WW
    Eur Psychiatry; 2005 Aug; 20(5-6):386-94. PubMed ID: 16171653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes toward antipsychotic medication, insight and psychopathology in outpatients with schizophrenia.
    Vassileva IV; Milanova VK
    Folia Med (Plovdiv); 2012; 54(4):62-8. PubMed ID: 23441471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
    Byerly MJ; Fisher R; Carmody T; Rush AJ
    J Clin Psychiatry; 2005 Aug; 66(8):997-1001. PubMed ID: 16086614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.
    Rettenbacher MA; Hofer A; Eder U; Hummer M; Kemmler G; Weiss EM; Fleischhacker WW
    J Clin Psychiatry; 2004 Sep; 65(9):1211-8. PubMed ID: 15367047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning.
    Kinon BJ; Noordsy DL; Liu-Seifert H; Gulliver AH; Ascher-Svanum H; Kollack-Walker S
    J Clin Psychopharmacol; 2006 Oct; 26(5):453-61. PubMed ID: 16974184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective and objective quality of life in schizophrenia.
    Narvaez JM; Twamley EW; McKibbin CL; Heaton RK; Patterson TL
    Schizophr Res; 2008 Jan; 98(1-3):201-8. PubMed ID: 17919890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.